About CorePharma

Focusing on Efficient Development of Strategic Pharmaceutical Products

CorePharma, founded in 1998, is a developer, manufacturer and marketer of high-quality, targeted, generic prescription pharmaceuticals across a variety of dosage forms and therapeutic categories. We specialize in difficult-to-develop high value products across a variety of therapeutic areas and currently produce almost one-half billion tablets and capsules annually. Our expertise in product development and manufacturing is complemented by robust sales, marketing and distribution capabilities.

CorePharma actively seeks partnerships, licensing and acquisition opportunities to complement and expand our product portfolio. By collaborating with innovative and trusted partners, we maximize the value of the relationship for all parties.

CorePharma currently operates four state-of-the-art facilities, totaling 115,000 square feet of space, in Middlesex, New Jersey. These facilities accommodate all research and development, manufacturing, packaging, and warehousing activities carried out by over 300 employees. These facilities are U.S. Food and Drug Administration (FDA) registered and licensed to manufacture and distribute controlled substances, Class C-II through C-V. We continually invest in manufacturing, packaging and testing facilities to improve efficiencies, ensure quality, add capacity and enhance technologies.

In 2005, RoundTable Healthcare Partners LLP, a leading global private equity firm, acquired a majority share of CorePharma.